References
- Baba T, Nakano H, Tamai K, Sawamura D, Hanada K, Hashimoto I, Arima Y. Inhibitory effect of beta-thujaplicin on ultraviolet B-induced apoptosis in mouse keratinocyte. J Invest Dermatol 1998; 110: 24–28
- Barichello JM, Handa H, Kisyuku M, Shibata T, Ishida T, Kiwada H. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: Creation of a drug supersaturated state. J Control Rel 2006; 115: 94–102
- Braun-Falco O, Korting HC, Maibach HI. Liposome dermatics. Springer-Verlag, Berlin 1992
- Buhl AE, Waldoln DJ, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol 1990a; 95: 553–557
- Buhl AE, Waldon DJ, Miller BF, Brumen MN. Differences in activity of minoxidil and cyclosporin A on hair growth in nude and normal mice. Lab Invest 1990b; 62: 104–107
- Burton JL, Marshall A. Hypertrichosis due to minoxidil. Br J Dermatol 1979; 101: 593–595
- Gregoriadis G. Liposomes as drug carriers. Wiley, New York 1988
- Guinebretière S, Briançon S, Fessi H, Teodorescu VS, Blanchin MG. Nanocapsules of biodegradable polymers: Preparation and characterization by direct high resolution electron microscopy. Mater Sci Eng C 2002; 21: 137–142
- Jiang H, Yamamoto S, Kato R. Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant. J Invest Dermatol 1995; 104: 523–525
- Kaufrnan KD. Clinical studies on the effects of oral finasteride, a type 5α-reductase inhibitor, on scalp hair in men with male pattern baldness. Hair research for the next millenium, D Neste. Elsevier, Amsterdam 1996; 363–365
- Kim JC, Lee MH, Rang MJ. Minoxidil-containing dosage forms. Drug Deliv 2003; 10: 119–123
- Kim JC, Song ME, Kim MJ, Lee EJ, Park SK, Rang MJ, Ahn HJ. Preparation and characterization of triclosan-containing vesicles. Colloid Surf B: Biointerfaces 2002; 26: 235–241
- Kim YS. Prevention of hair loss and compositions for hair growth promotion 2003, Korean Patent 10-2003-0041638
- Manosroi A, Kongkaneramit L, Manosroi J. Stability and transdermal absorption of topical amphotericin B liposome formulations. Int J Pharm 2004; 270: 279–286
- Meisheri KD, Cipkus LA, Tayor CJ. Mechanism of action of minoxidil suIfate-induced vasodilation: A role for increased K+ permeability. J Pharmacol Exp Ther 1998; 245: 751–760
- Morita Y, Matusumura E, Okabe T, Fukui T, Ohe T, Ishida N, Inamori Y. Biological activity of β-dolabin, γ-thujaplicin, and 4-acetyltropolone hinokitiol-related compounds. Biol Pharm Bull 2004; 27: 1666–1669
- Nomiya K, Yoshizawa A, Kasuga NC, Yokoyama H, Hirakawa S. Synthesis, solid-state characterization and antimicrobial activities of three different polymophs of a copper (II) complex with 4-isopropyltropolone (hinokitiol). Inorg Chim Acta 2004; 357: 1168–1176
- Singh AK, Das J. Liposome encapsulated vitamin A compounds exhibit greater stability and diminished toxicity. Biophys Chem 1998; 73: 155–162
- Song HH. Hair growth promotion agents and a screening method for the agents 2003, Korean Patent 10-2003-7003542
- Song ME, Kim JC, Kim TS, Park HS, Rang MJ. Silicone compound-containing shampoo composition having good phase stability 2002, Korean Patent 2002-0009941
- Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Rel 2003; 70: 1–20
- Stenn KS. The molecular and structural biology of hair: Introduction. Ann NY Acad Sci 1991; 642: 11–13
- Wolfram LJ. Methods for claim support in cosmetology: Hair cosmetics. Cosmetics: Controlled efficacy studies and regulation, P Elsner, HF Merk, HI Maibach. Springer, Berlin 1999; 175–196
- Yavuz H, Babaç C, Tuzlakolu K, Pikin E. Preparation and degradation of L-lactide and ε-caprolactone homo and copolymer films. Polym Degrad Stab 2002; 75: 431–437
- Yoon KS, Lee CS, Park HS. Hair cosmetic composition 2004, Korean Patent 10-0461085-0000